Product Code:148600
Published Date: Aug 08,2020
Pages: 135
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this study, over the next five years the Polio Vaccine market will register a 5.5%% CAGR in terms of revenue, the global market size will reach $ 1638.1 million by 2025, from $ 1322.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Polio Vaccine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries. This study specially analyses the impact of Covid-19 outbreak on the Polio Vaccine, covering the supply chain analysis, impact assessment to the Polio Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Polio Vaccine companies in response to the COVID-19 epidemic. Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7. Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV) Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8. Public Private This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Sanofi GSK Serum Institute Tiantan Biological Bibcol Bio-Med IMBCA Halfkin Bio-Pharmaceuticals Panacea Biotec Ltd In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global Polio Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025. To understand the structure of Polio Vaccine market by identifying its various subsegments. Focuses on the key global Polio Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Polio Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Polio Vaccine submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polio Vaccine Consumption 2015-2025
2.1.2 Polio Vaccine Consumption CAGR by Region
2.2 Polio Vaccine Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Polio Vaccine Consumption by Type
2.3.1 Global Polio Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Polio Vaccine Sale Price by Type (2015-2020)
2.4 Polio Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Polio Vaccine Consumption by Application
2.5.1 Global Polio Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Polio Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Polio Vaccine Sale Price by Type (2015-2020)
3 Global Polio Vaccine by Company
3.1 Global Polio Vaccine Sales Market Share by Company
3.1.1 Global Polio Vaccine Sales by Company (2018-2020)
3.1.2 Global Polio Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Polio Vaccine Revenue Market Share by Company
3.2.1 Global Polio Vaccine Revenue by Company (2018-2020)
3.2.2 Global Polio Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Polio Vaccine Sale Price by Company
3.4 Global Polio Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Polio Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Polio Vaccine by Regions
4.1 Polio Vaccine by Regions
4.2 Americas Polio Vaccine Consumption Growth
4.3 APAC Polio Vaccine Consumption Growth
4.4 Europe Polio Vaccine Consumption Growth
4.5 Middle East & Africa Polio Vaccine Consumption Growth
5 Americas
5.1 Americas Polio Vaccine Consumption by Countries
5.1.1 Americas Polio Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Polio Vaccine Value by Countries (2015-2020)
5.2 Americas Polio Vaccine Consumption by Type
5.3 Americas Polio Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Polio Vaccine Consumption by Regions
6.1.1 APAC Polio Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Polio Vaccine Value by Regions (2015-2020)
6.2 APAC Polio Vaccine Consumption by Type
6.3 APAC Polio Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Polio Vaccine by Countries
7.1.1 Europe Polio Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Polio Vaccine Value by Countries (2015-2020)
7.2 Europe Polio Vaccine Consumption by Type
7.3 Europe Polio Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Polio Vaccine by Countries
8.1.1 Middle East & Africa Polio Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Polio Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Polio Vaccine Consumption by Type
8.3 Middle East & Africa Polio Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Polio Vaccine Distributors
10.3 Polio Vaccine Customer
11 Global Polio Vaccine Market Forecast
11.1 Global Polio Vaccine Consumption Forecast (2021-2025)
11.2 Global Polio Vaccine Forecast by Regions
11.2.1 Global Polio Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Polio Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Polio Vaccine Forecast by Type
11.8 Global Polio Vaccine Forecast by Application
12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Polio Vaccine Product Offered
12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Polio Vaccine Product Offered
12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Serum Institute
12.3.1 Company Information
12.3.2 Polio Vaccine Product Offered
12.3.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Serum Institute Latest Developments
12.4 Tiantan Biological
12.4.1 Company Information
12.4.2 Polio Vaccine Product Offered
12.4.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Tiantan Biological Latest Developments
12.5 Bibcol
12.5.1 Company Information
12.5.2 Polio Vaccine Product Offered
12.5.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bibcol Latest Developments
12.6 Bio-Med
12.6.1 Company Information
12.6.2 Polio Vaccine Product Offered
12.6.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bio-Med Latest Developments
12.7 IMBCA
12.7.1 Company Information
12.7.2 Polio Vaccine Product Offered
12.7.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 IMBCA Latest Developments
12.8 Halfkin Bio-Pharmaceuticals
12.8.1 Company Information
12.8.2 Polio Vaccine Product Offered
12.8.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Halfkin Bio-Pharmaceuticals Latest Developments
12.9 Panacea Biotec Ltd
12.9.1 Company Information
12.9.2 Polio Vaccine Product Offered
12.9.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Panacea Biotec Ltd Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Polio Vaccine Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Inactivated Polio Vaccine (IPV) Table 5. Major Players of Oral Polio Vaccine (OPV) Table 6. Global Consumption Sales by Type (2015-2020) Table 7. Global Polio Vaccine Consumption Market Share by Type (2015-2020) Table 8. Global Polio Vaccine Revenue by Type (2015-2020) ($ million) Table 9. Global Polio Vaccine Value Market Share by Type (2015-2020) ($ Millions) Table 10. Global Polio Vaccine Sale Price by Type (2015-2020) Table 11. Global Consumption Sales by Application (2015-2020) Table 12. Global Polio Vaccine Consumption Market Share by Application (2015-2020) Table 13. Global Polio Vaccine Value by Application (2015-2020) Table 14. Global Polio Vaccine Value Market Share by Application (2015-2020) Table 15. Global Polio Vaccine Sale Price by Application (2015-2020) Table 16. Global Polio Vaccine Sales by Company (2017-2019) (M Doses) Table 17. Global Polio Vaccine Sales Market Share by Company (2017-2019) Table 18. Global Polio Vaccine Revenue by Company (2017-2019) ($ Millions) Table 19. Global Polio Vaccine Revenue Market Share by Company (2017-2019) Table 20. Global Polio Vaccine Sale Price by Company (2017-2019) Table 21. Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers Table 22. Players Polio Vaccine Products Offered Table 23. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 24. Global Polio Vaccine Consumption by Regions 2015-2020 (M Doses) Table 25. Global Polio Vaccine Consumption Market Share by Regions 2015-2020 Table 26. Global Polio Vaccine Value by Regions 2015-2020 ($ Millions) Table 27. Global Polio Vaccine Value Market Share by Regions 2015-2020 Table 28. Americas Polio Vaccine Consumption by Countries (2015-2020) (M Doses) Table 29. Americas Polio Vaccine Consumption Market Share by Countries (2015-2020) Table 30. Americas Polio Vaccine Value by Countries (2015-2020) ($ Millions) Table 31. Americas Polio Vaccine Value Market Share by Countries (2015-2020) Table 32. Americas Polio Vaccine Consumption by Type (2015-2020) (M Doses) Table 33. Americas Polio Vaccine Consumption Market Share by Type (2015-2020) Table 34. Americas Polio Vaccine Consumption by Application (2015-2020) (M Doses) Table 35. Americas Polio Vaccine Consumption Market Share by Application (2015-2020) Table 36. APAC Polio Vaccine Consumption by Countries (2015-2020) (M Doses) Table 37. APAC Polio Vaccine Consumption Market Share by Countries (2015-2020) Table 38. APAC Polio Vaccine Value by Regions (2015-2020) ($ Millions) Table 39. APAC Polio Vaccine Value Market Share by Regions (2015-2020) Table 40. APAC Polio Vaccine Consumption by Type (2015-2020) (M Doses) Table 41. APAC Polio Vaccine Consumption Market Share by Type (2015-2020) Table 42. APAC Polio Vaccine Consumption by Application (2015-2020) (M Doses) Table 43. APAC Polio Vaccine Consumption Market Share by Application (2015-2020) Table 44. Europe Polio Vaccine Consumption by Countries (2015-2020) (M Doses) Table 45. Europe Polio Vaccine Consumption Market Share by Countries (2015-2020) Table 46. Europe Polio Vaccine Value by Countries (2015-2020) ($ Millions) Table 47. Europe Polio Vaccine Value Market Share by Countries (2015-2020) Table 48. Europe Polio Vaccine Consumption by Type (2015-2020) (M Doses) Table 49. Europe Polio Vaccine Consumption Market Share by Type (2015-2020) Table 50. Europe Polio Vaccine Consumption by Application (2015-2020) (M Doses) Table 51. Europe Polio Vaccine Consumption Market Share by Application (2015-2020) Table 52. Middle East & Africa Polio Vaccine Consumption by Countries (2015-2020) (M Doses) Table 53. Middle East & Africa Polio Vaccine Consumption Market Share by Countries (2015-2020) Table 54. Middle East & Africa Polio Vaccine Value by Countries (2015-2020) ($ Millions) Table 55. Middle East & Africa Polio Vaccine Value Market Share by Countries (2015-2020) Table 56. Middle East & Africa Polio Vaccine Consumption by Type (2015-2020) (M Doses) Table 57. Middle East & Africa Polio Vaccine Consumption Market Share by Type (2015-2020) Table 58. Middle East & Africa Polio Vaccine Consumption by Application (2015-2020) (M Doses) Table 59. Middle East & Africa Polio Vaccine Consumption Market Share by Application (2015-2020) Table 60. Polio Vaccine Distributors List Table 61. Polio Vaccine Customer List Table 62. Global Polio Vaccine Consumption Forecast by Countries (2021-2025) (M Doses) Table 63. Global Polio Vaccine Consumption Market Forecast by Regions Table 64. Global Polio Vaccine Value Forecast by Countries (2021-2025) ($ Millions) Table 65. Global Polio Vaccine Value Market Share Forecast by Regions Table 66. Global Polio Vaccine Consumption Forecast by Type (2021-2025) (M Doses) Table 67. Global Polio Vaccine Consumption Market Share Forecast by Type (2021-2025) Table 68. Global Polio Vaccine Value Forecast by Type (2021-2025) ($ Millions) Table 69. Global Polio Vaccine Value Market Share Forecast by Type (2021-2025) Table 70. Global Polio Vaccine Consumption Forecast by Application (2021-2025) (M Doses) Table 71. Global Polio Vaccine Consumption Market Share Forecast by Application (2021-2025) Table 72. Global Polio Vaccine Value Forecast by Application (2021-2025) ($ Millions) Table 73. Global Polio Vaccine Value Market Share Forecast by Application (2021-2025) Table 74. Sanofi Product Offered Table 75. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 76. Sanofi Main Business Table 77. Sanofi Latest Developments Table 78. Sanofi Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 79. GSK Product Offered Table 80. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 81. GSK Main Business Table 82. GSK Latest Developments Table 83. GSK Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 84. Serum Institute Product Offered Table 85. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 86. Serum Institute Main Business Table 87. Serum Institute Latest Developments Table 88. Serum Institute Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 89. Tiantan Biological Product Offered Table 90. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 91. Tiantan Biological Main Business Table 92. Tiantan Biological Latest Developments Table 93. Tiantan Biological Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 94. Bibcol Product Offered Table 95. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 96. Bibcol Main Business Table 97. Bibcol Latest Developments Table 98. Bibcol Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 99. Bio-Med Product Offered Table 100. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 101. Bio-Med Main Business Table 102. Bio-Med Latest Developments Table 103. Bio-Med Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 104. IMBCA Product Offered Table 105. IMBCA Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 106. IMBCA Main Business Table 107. IMBCA Latest Developments Table 108. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 109. Halfkin Bio-Pharmaceuticals Product Offered Table 110. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 111. Halfkin Bio-Pharmaceuticals Main Business Table 112. Halfkin Bio-Pharmaceuticals Latest Developments Table 113. Halfkin Bio-Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 114. Panacea Biotec Ltd Product Offered Table 115. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E) Table 116. Panacea Biotec Ltd Main Business Table 117. Panacea Biotec Ltd Latest Developments Table 118. Panacea Biotec Ltd Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of Polio Vaccine Figure 2. Polio Vaccine Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Polio Vaccine Consumption Growth Rate 2015-2025 (M Doses) Figure 5. Global Polio Vaccine Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Inactivated Polio Vaccine (IPV) Figure 7. Product Picture of Oral Polio Vaccine (OPV) Figure 8. Global Polio Vaccine Consumption Market Share by Type (2015-2020) Figure 9. Global Polio Vaccine Value Market Share by Type (2015-2020) Figure 10. Polio Vaccine Consumed in Public Figure 11. Global Polio Vaccine Market: Public (2015-2020) (M Doses) Figure 12. Global Polio Vaccine Market: Public (2015-2020) ($ Millions) Figure 13. Polio Vaccine Consumed in Private Figure 14. Global Polio Vaccine Market: Private (2015-2020) (M Doses) Figure 15. Global Polio Vaccine Market: Private (2015-2020) ($ Millions) Figure 16. Global Polio Vaccine Consumption Market Share by Application (2015-2020) Figure 17. Global Polio Vaccine Value Market Share by Application (2015-2020) Figure 18. Global Polio Vaccine Sales Market Share by Company in 2017 Figure 19. Global Polio Vaccine Sales Market Share by Company in 2019 Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2017 Figure 21. Global Polio Vaccine Revenue Market Share by Company in 2019 Figure 22. Global Polio Vaccine Sale Price by Company in 2019 Figure 23. Global Polio Vaccine Consumption Market Share by Regions 2015-2020 Figure 24. Global Polio Vaccine Value Market Share by Regions 2015-2020 Figure 25. Americas Polio Vaccine Consumption 2015-2020 (M Doses) Figure 26. Americas Polio Vaccine Value 2015-2020 ($ Millions) Figure 27. APAC Polio Vaccine Consumption 2015-2020 (M Doses) Figure 28. APAC Polio Vaccine Value 2015-2020 ($ Millions) Figure 29. Europe Polio Vaccine Consumption 2015-2020 (M Doses) Figure 30. Europe Polio Vaccine Value 2015-2020 ($ Millions) Figure 31. Middle East & Africa Polio Vaccine Consumption 2015-2020 (M Doses) Figure 32. Middle East & Africa Polio Vaccine Value 2015-2020 ($ Millions) Figure 33. Americas Polio Vaccine Consumption Market Share by Countries in 2019 Figure 34. Americas Polio Vaccine Value Market Share by Countries in 2019 Figure 35. Americas Polio Vaccine Consumption Market Share by Type in 2019 Figure 36. Americas Polio Vaccine Consumption Market Share by Application in 2019 Figure 37. United States Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 38. United States Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 39. Canada Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 40. Canada Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 41. Mexico Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 42. Mexico Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 43. APAC Polio Vaccine Consumption Market Share by Countries in 2019 Figure 44. APAC Polio Vaccine Value Market Share by Regions in 2019 Figure 45. APAC Polio Vaccine Consumption Market Share by Type in 2019 Figure 46. APAC Polio Vaccine Consumption Market Share by Application in 2019 Figure 47. China Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 48. China Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 49. Japan Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 50. Japan Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 51. Korea Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 52. Korea Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 53. Southeast Asia Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 54. Southeast Asia Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 55. India Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 56. India Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 57. Australia Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 58. Australia Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 59. Europe Polio Vaccine Consumption Market Share by Countries in 2019 Figure 60. Europe Polio Vaccine Value Market Share by Countries in 2019 Figure 61. Europe Polio Vaccine Consumption Market Share by Type in 2019 Figure 62. Europe Polio Vaccine Consumption Market Share by Application in 2019 Figure 63. Germany Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 64. Germany Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 65. France Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 66. France Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 67. UK Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 68. UK Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 69. Italy Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 70. Italy Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 71. Russia Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 72. Russia Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 73. Middle East & Africa Polio Vaccine Consumption Market Share by Countries in 2019 Figure 74. Middle East & Africa Polio Vaccine Value Market Share by Countries in 2019 Figure 75. Middle East & Africa Polio Vaccine Consumption Market Share by Type in 2019 Figure 76. Middle East & Africa Polio Vaccine Consumption Market Share by Application in 2019 Figure 77. Egypt Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 78. Egypt Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 79. South Africa Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 80. South Africa Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 81. Israel Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 82. Israel Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 83. Turkey Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 84. Turkey Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 85. GCC Countries Polio Vaccine Consumption Growth 2015-2020 (M Doses) Figure 86. GCC Countries Polio Vaccine Value Growth 2015-2020 ($ Millions) Figure 87. Global Polio Vaccine Consumption Growth Rate Forecast (2021-2025) (M Doses) Figure 88. Global Polio Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 89. Americas Polio Vaccine Consumption 2021-2025 (M Doses) Figure 90. Americas Polio Vaccine Value 2021-2025 ($ Millions) Figure 91. APAC Polio Vaccine Consumption 2021-2025 (M Doses) Figure 92. APAC Polio Vaccine Value 2021-2025 ($ Millions) Figure 93. Europe Polio Vaccine Consumption 2021-2025 (M Doses) Figure 94. Europe Polio Vaccine Value 2021-2025 ($ Millions) Figure 95. Middle East & Africa Polio Vaccine Consumption 2021-2025 (M Doses) Figure 96. Middle East & Africa Polio Vaccine Value 2021-2025 ($ Millions) Figure 97. United States Polio Vaccine Consumption 2021-2025 (M Doses) Figure 98. United States Polio Vaccine Value 2021-2025 ($ Millions) Figure 99. Canada Polio Vaccine Consumption 2021-2025 (M Doses) Figure 100. Canada Polio Vaccine Value 2021-2025 ($ Millions) Figure 101. Mexico Polio Vaccine Consumption 2021-2025 (M Doses) Figure 102. Mexico Polio Vaccine Value 2021-2025 ($ Millions) Figure 103. Brazil Polio Vaccine Consumption 2021-2025 (M Doses) Figure 104. Brazil Polio Vaccine Value 2021-2025 ($ Millions) Figure 105. China Polio Vaccine Consumption 2021-2025 (M Doses) Figure 106. China Polio Vaccine Value 2021-2025 ($ Millions) Figure 107. Japan Polio Vaccine Consumption 2021-2025 (M Doses) Figure 108. Japan Polio Vaccine Value 2021-2025 ($ Millions) Figure 109. Korea Polio Vaccine Consumption 2021-2025 (M Doses) Figure 110. Korea Polio Vaccine Value 2021-2025 ($ Millions) Figure 111. Southeast Asia Polio Vaccine Consumption 2021-2025 (M Doses) Figure 112. Southeast Asia Polio Vaccine Value 2021-2025 ($ Millions) Figure 113. India Polio Vaccine Consumption 2021-2025 (M Doses) Figure 114. India Polio Vaccine Value 2021-2025 ($ Millions) Figure 115. Australia Polio Vaccine Consumption 2021-2025 (M Doses) Figure 116. Australia Polio Vaccine Value 2021-2025 ($ Millions) Figure 117. Germany Polio Vaccine Consumption 2021-2025 (M Doses) Figure 118. Germany Polio Vaccine Value 2021-2025 ($ Millions) Figure 119. France Polio Vaccine Consumption 2021-2025 (M Doses) Figure 120. France Polio Vaccine Value 2021-2025 ($ Millions) Figure 121. UK Polio Vaccine Consumption 2021-2025 (M Doses) Figure 122. UK Polio Vaccine Value 2021-2025 ($ Millions) Figure 123. Italy Polio Vaccine Consumption 2021-2025 (M Doses) Figure 124. Italy Polio Vaccine Value 2021-2025 ($ Millions) Figure 125. Russia Polio Vaccine Consumption 2021-2025 (M Doses) Figure 126. Russia Polio Vaccine Value 2021-2025 ($ Millions) Figure 127. Spain Polio Vaccine Consumption 2021-2025 (M Doses) Figure 128. Spain Polio Vaccine Value 2021-2025 ($ Millions) Figure 129. Egypt Polio Vaccine Consumption 2021-2025 (M Doses) Figure 130. Egypt Polio Vaccine Value 2021-2025 ($ Millions) Figure 131. South Africa Polio Vaccine Consumption 2021-2025 (M Doses) Figure 132. South Africa Polio Vaccine Value 2021-2025 ($ Millions) Figure 133. Israel Polio Vaccine Consumption 2021-2025 (M Doses) Figure 134. Israel Polio Vaccine Value 2021-2025 ($ Millions) Figure 135. Turkey Polio Vaccine Consumption 2021-2025 (M Doses) Figure 136. Turkey Polio Vaccine Value 2021-2025 ($ Millions) Figure 137. GCC Countries Polio Vaccine Consumption 2021-2025 (M Doses) Figure 138. GCC Countries Polio Vaccine Value 2021-2025 ($ Millions) Figure 139. Sanofi Polio Vaccine Market Share (2018-2020) Figure 140. GSK Polio Vaccine Market Share (2018-2020) Figure 141. Serum Institute Polio Vaccine Market Share (2018-2020) Figure 142. Tiantan Biological Polio Vaccine Market Share (2018-2020) Figure 143. Bibcol Polio Vaccine Market Share (2018-2020) Figure 144. Bio-Med Polio Vaccine Market Share (2018-2020) Figure 145. IMBCA Polio Vaccine Market Share (2018-2020) Figure 146. Halfkin Bio-Pharmaceuticals Polio Vaccine Market Share (2018-2020) Figure 147. Panacea Biotec Ltd Polio Vaccine Market Share (2018-2020)
Sanofi GSK Serum Institute Tiantan Biological Bibcol Bio-Med IMBCA Halfkin Bio-Pharmaceuticals Panacea Biotec Ltd
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
Global Polio Vaccine Market Growth 2024-2030
Pages: 94|Category: PHARMA & HEALTHCARE
According to our LPI (LP Information) latest study, the global Polio Vaccine market size was valued at US$ 694.4 million in 2023. With growing demand in downstream market, the Polio Vaccine is forecast to a readjusted size of US$ 935.9 million by 2030 with a CAGR of 4.4% during review period.
$3660.00
Jun
2021
Global Polio Vaccine Market Growth 2021-2026
Pages: 95|Category: PHARMA & HEALTHCARE
According to this latest study, the 2021 growth of Polio Vaccine will have significant change from previous year. By the most conservative estimates of global Polio Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 655 million in 2020. Over the next five years the Polio Vaccine market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 775.5 million by 2026.
$3660.00